AntiCancer Technology


Theralase Technologies is currently performing human clinical studies on patients with

non-muscle invasive bladder cancer. 

More details >

Theralase is currently enrolling for a Phase Ib Non-Muscle Invasive Bladder Cancer Clinical Study. 

For patients wishing to inquire about enrolling in the study or practitioners wishing to enroll their patients please fill out the following form:



Theralase's research and development activities are organized into two principal divisions:


Therapeutic Laser Technology (TLT)

The Therapeutic Laser Technology (TLT) Division, which focuses on the development and commercialization of laser-based biomodulation, a non-invasive reparative biomedical platform technology targeting tissue inflammation, degeneration and pain. The FDA, Health Canada and CE have approved our core advanced therapeutic laser technology.

Photo Dynamic Therapy (PDT)

Theralase develops advanced pharmaceutical products and medical devices based on proprietary non-immunosuppressive photodynamic technology, targeting key health care and oncology markets. Theralase’s strategy is to build a specialty Biopharma company by developing and commercializing new and innovative products based on its patented photodynamic compounds, lasers, drug and light delivery systems, personalized and a patient specific platform technologies. Theralase’s strategy in oncology is to continue the research & development of the anti-cancer portfolio, with transition metal –based Photodynamic Compounds (DDCs) and other new anti-cancer products, and build a commercial platform in Canada and US for clinical use worldwide.


One of Theralase’s strategies in the general healthcare segment is to continue the development of the anti- microbial PDT portfolio for infection control & sterilization. This strategy is based on a strong and comprehensive platform of intellectual property in Photodynamic Therapy.



What is PDT?

Photodynamic therapy (PDT), sometimes called photochemotherapy, is a form of phototherapy using nontoxic light-sensitive compounds that are exposed selectively to light. When photosensitizers are exposed to a specific wavelength of light, they produce a form of oxygen known as Reactive Oxygen Species (ROS), which is able to destroy resident cells through natural cell death, known as apoptosis.

Each photosensitizer is activated by light of a specific wavelength. This wavelength determines how far the light can travel into the body.

Benefits of PDT

It has no long-term side effects when used properly.

It’s less invasive than surgery.

It usually takes only a short time and is most often done as an outpatient.

It can be targeted very precisely.

Unlike radiation, PDT can be repeated many times at the same site if needed.

There’s little or no scarring after the site heals.

It often costs less than other cancer treatments.


PDT Research Papers